PARP1 and neoplasm: Apart from DSBs that are left unrepaired, with PARP inhibitors in BRCA-deficient tumor cells as the main mechanism for synthetic lethality, recent studies have suggested an alternative mechanism in which replication gaps in SSBs are critical for sensitivity to PARP inhibitors [44,45].